DANIEL WHITMER: Open Payments
NPI 1649377391 · BEAVERCREEK, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,281 in 20 payments from 8 companies in 2025. Trend: 2023 $740 · 2024 $1,185 · 2025 $3,281
Travel & lodging: $1,939Food & beverage: $1,343
| Company | Payments | Amount |
|---|---|---|
| Genentech, Inc. | 7 | $2,621 |
| Janssen Pharmaceuticals, Inc | 2 | $166 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $159 |
| Phathom Pharmaceuticals, Inc. | 1 | $125 |
| ABBVIE INC. | 1 | $99 |
| Lilly USA, LLC | 4 | $76 |
| Novartis Pharmaceuticals Corporation | 1 | $20 |
| Astellas Pharma US Inc | 1 | $14 |
Products named: SPRAVATO, CAPLYTA, VOQUEZNA, VRAYLAR, ZEPBOUND, MOUNJARO, LEQVIO, Veozah.
Industry payments across OH — which companies pay providers there.
